passage bio stock news

What are analysts forecasts for Passage Bio stock. Passage Bio Announces 2022 Research and Clinical Development Goals to Advance Robust CNS Pipeline.

Passage Bio Stock Worth Keeping An Eye On Nasdaq Pasg Seeking Alpha

13 hours agoPassage Bio Price Performance.

. PBFT02 which utilizes an. This is the News-site for the company Passage Bio on Markets Insider. Is followed by the analysts listed above.

Stock on our page and stay on top of the game. The high in the last 52 weeks of Passage Bio stock was 1334. According to the current price Passage Bio is 1402 away from the 52-week high.

Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools. Passage Bio to Report First Quarter 2022 Financial Results on May 16 2022. Passage Bio to Report Second Quarter 2022 Financial Results on August 4 2022.

View the latest Passage Bio Inc. PASG stock price quote stock graph news analysis. Get the latest Passage Bio Inc PASG real-time quote historical performance charts and other financial information to help you make more informed trading and investment decisions.

Passage Bio has a 1-year low of 157 and a 1-year high of 1308. The stock has a fifty day moving average price of 223 and a two-hundred day moving average price of 292. The stock is currently down 583 year-to-date down 260 over the.

13 hours agoPassage Bio Stock Performance. Get Passage Bio Inc PASGNASDAQ real-time stock quotes news price and financial information from CNBC. PASG stock price news historical charts analyst ratings and financial information from WSJ.

Shares of NASDAQ PASG opened at 177 on Tuesday. A high-level overview of Passage Bio Inc. Find the latest news headlines from Passage Bio Inc.

Passage Bio to Present at the 40th Annual JP. Passage Bio owners buys 168300 shares worth 910K. It develops PBGM01 which utilizes a proprietary AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1.

Find the latest news for Passage Bio Inc. The business has a 50-day moving average of 2. Passage Bio stock price target cut to 9 from 16 at Wedbush.

Passage Bio Inc a genetic medicines company develops transformative therapies for central nervous system diseases. By accessing this page you agree to the following. Data News supplied by wwwcloudquoteio Stock quotes supplied by Barchart Quotes delayed at least 20 minutes.

Passage Bio Inc PASG shares closed today at 09 above its 52 week low of 1056 giving the company a market cap of 576M. Articles published by Passage Bio. Shares of NASDAQ PASG opened at 177 on Tuesday.

Real time Passage Bio Inc. Please note that any opinions estimates or forecasts regarding Passage Bio Incs performance made by these analysts are theirs alone and do not represent opinions forecasts or predictions of Passage Bio.

Passage Bio Inc Investors And News Stock Information